Outcomes in Systemic Sclerosis-Associated Interstitial Lung Disease Based on Serological Profiles: Focus on Anti-Centromere and Anti-RNA Polymerase III Antibodies

Volkmann, E. R., Assassi, S., Denton, C. P., Simonovska, R., Sambevski, S., Alves, M., & Bernstein, E. J. (2025). Outcomes in Systemic Sclerosis-Associated Interstitial Lung Disease Based on Serological Profiles: Focus on Anti-Centromere and Anti-RNA Polymerase III Antibodies. The Journal of Rheumatology, jrheum.2024-1063. https://doi.org/10.3899/jrheum.2024-1063
Authors:
Elizabeth R Volkmann
Shervin Assassi
Christopher P Denton
Rozeta Simonovska
Steven Sambevski
Margarida Alves
Elana J Bernstein
Affiliated Authors:
Elana J Bernstein
Publication Type:
Article
Unique ID:
10.3899/jrheum.2024-1063
PMID:
Publication Date:
Data Source:
PubMed

Record Created: